Zwielichtige Vergangenheit
www.fool.com/investing/2018/07/02/...g-obliterated-today.aspx
|
Zwielichtige Vergangenheit
www.fool.com/investing/2018/07/02/...g-obliterated-today.aspx
Chaos pur! Insolvenzgefahr?
www.marketwatch.com/story/...nd-its-new-auditor-ey-2018-07-02
Anhörung am 13. September
seekingalpha.com/news/...ext-month-shares-1-percent-premarket
Nasdaq Delisting
mimedx.gcs-web.com/news-releases/...aq-delisting-notification
streicht Stellen
endpts.com/...f-its-workforce-in-the-wake-of-a-c-suite-purge/
zwei Studien verfehlen den primären Endpunkt
- Top-line results from an interim analysis of the Phase 2B trial for KOA did not meet primary endpoints
- Top-line results from Phase 3 Plantar Fasciitis trial did not meet its primary endpoints
www.sec.gov/Archives/edgar/data/1376339/...linicaltrialre.htm
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
14 | MDXG 3,93$ (-39%) | Vassago | Vassago | 16.09.21 18:15 |